Science Explorer Back to mapMap
Discussion
Researcher · Centre Jean Perrin · France

Pascale Dubray‐Longeras

Pascale Dubray‐Longeras publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Sarcoma Diagnosis and Treatment, Cancer Treatment and Pharmacology and Breast Cancer Treatment Studies.

OpenAlex
World rank
#1,326,960
of 7,710,434 ranked researchers
Rank in France
#60,447
of 324,115
Works
80
Citations
1.4k
Citations per work
18.0
h-index
16
i10-index 26Top 33% in Oncology
Pascale Dubray‐Longeras

What does Pascale Dubray‐Longeras research?

Pascale Dubray‐Longeras's work is mostly in Medicine (72%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 58 works · 72.1% of their workMedicine: 58 works · 72.1% of their workOncology: 24 works · 29.6% of their workPulmonary and Respiratory Medicine: 22 works · 27.4% of their workRheumatology: 5 works · 6.1% of their workPathology and Forensic Medicine: 4 works · 4.5% of their workSurgery: 4 works · 4.5% of their workEverything else: 13 works · 16.7% of their workLife Sciences: 9 works · 11.2% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 11.2% of their workCancer Research: 9 works · 11.2% of their workTHEIR WORKPascaleDubray‐Longeras80works
Life Sciences11%Health Sciences72%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5872.1%
  2. Everything else1316.7%
    1. Biochemistry, Genetics and Molecular Biology911.2%
  1. 1Oncology30% of their works
  2. 2Pulmonary and Respiratory Medicine27% of their works
  3. 3Cancer Research11% of their works
  4. 4Rheumatology6% of their works
  5. 5Pathology and Forensic Medicine4% of their works
  6. 6Surgery4% of their works

Research topics

Which keywords describe Pascale Dubray‐Longeras's research?

The keywords of their largest research topics: Clinical Practice Guidelines, Chemotherapy, Prognostic Factors, Osteosarcoma, Soft Tissue Sarcoma, Radiotherapy, Targeted Therapy and Chemotherapy-Induced Peripheral Neuropathy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Clinical Practice Guidelines352 topics
  2. Chemotherapy292 topics
  3. Prognostic Factors292 topics
  4. Osteosarcoma221 topic
  5. Soft Tissue Sarcoma221 topic
  6. Radiotherapy202 topics
  7. Targeted Therapy182 topics
  8. Chemotherapy-Induced Peripheral Neuropathy141 topic
  9. Taxanes141 topic
  10. Breast Tumours131 topic
  11. Gene Expression131 topic
  12. ALK Inhibitors121 topic
  13. EGFR Mutations121 topic
  14. Angiosarcoma71 topic
  15. CT Screening71 topic
  16. Desmoid Tumor71 topic
  17. Epithelioid Hemangioendothelioma71 topic
  18. Lung Cancer71 topic
  19. Solitary Fibrous Tumor71 topic
  20. Cancer Genomics61 topic
  21. Mutational Signatures61 topic

Where does Pascale Dubray‐Longeras work?

Pascale Dubray‐Longeras's main affiliation in the publication record is Centre Jean Perrin, France.

How many publications and citations does Pascale Dubray‐Longeras have?

OpenAlex counts 80 works and 1,437 citations for Pascale Dubray‐Longeras, an h-index of 16, ranking #1,326,960 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Pascale Dubray‐Longeras. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.